Cardiology overview heart failure: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Cardiology overview}} | {{Cardiology overview}} | ||
{{CMG}} | {{CMG}} | ||
==Pharmacotherapy== | |||
===Lasix=== | |||
*Higher lasix doses are associated with higher mortality, likely as a surrogate of disease severity rather than part of a causal pathway. | |||
Revision as of 15:17, 31 October 2011
|
Cardiology Overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Pharmacotherapy
Lasix
- Higher lasix doses are associated with higher mortality, likely as a surrogate of disease severity rather than part of a causal pathway.
Obstructive Sleep Apnea in the Patient with CHF
- Central sleep apnea in the patient with CHF is due to the compensatory respiratory alkalosis that is present in the patient with CHF and tachypnea